3-(2-氯乙基)-2-甲基-9-羟基-4H-吡啶并[1,2A]嘧啶-4酮 (帕潘立酮),3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (Paliperidone),分析标准品,99%
产品编号:Bellancom-YE105911| CAS NO:260273-82-3| 分子式:C11H11ClN2O2| 分子量:238.673
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
英文名称 | 3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (Paliperidone) |
---|---|
CAS编号 | 260273-82-3 |
产品沸点 | 413.1±55.0 °C at 760 mmHg |
产品密度 | 1.4±0.1 g/cm3 |
产品闪点 | 203.6±31.5 °C |
精确质量 | 238.050903 |
PSA | 54.60000 |
LogP | 1.66 |
蒸气压 | 0.0±2.2 mmHg at 25°C |
折射率 | 1.635 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
~% ![]() 260273-82-3 |
文献:ACTAVIS GROUP PTC EHF Patent: US2010/4447 A1, 2010 ; Location in patent: Page/Page column 3 ; |
~63% ![]() 260273-82-3 |
文献:GLENMARK GENERICS LIMITED Patent: WO2009/130710 A2, 2009 ; Location in patent: Page/Page column 17-18 ; |
~% ![]() 260273-82-3 |
文献:WATSON LABORATORIES, INC.; CHAVAN, Amit, Anant; BHANU, Manjunath, Narayan; JOSHI, Ashutosh, Vijay Patent: WO2012/134445 A1, 2012 ; Location in patent: Page/Page column 26; 27 ; |
~% ![]() 260273-82-3 |
文献:CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PATEL, Dhimant, Jasubhai; ROY, Rushikesh, Udaykumar; PATEL, Mayur, Ramnikbhai Patent: WO2011/73997 A2, 2011 ; |
~% ![]() 260273-82-3 |
文献:CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PATEL, Dhimant, Jasubhai; ROY, Rushikesh, Udaykumar; PATEL, Mayur, Ramnikbhai Patent: WO2011/73997 A2, 2011 ; |
~% ![]() 260273-82-3 |
文献:CADILA HEALTHCARE LIMITED; DWIVEDI, Shriprakash, Dhar; PATEL, Dhimant, Jasubhai; ROY, Rushikesh, Udaykumar; PATEL, Mayur, Ramnikbhai Patent: WO2011/73997 A2, 2011 ; Location in patent: Page/Page column 14 ; |